Unique ID issued by UMIN | UMIN000058239 |
---|---|
Receipt number | R000066578 |
Scientific Title | A Non-Inferiority Study of 0.8% Lugol's Iodine Staining versus 1.5% for the Detection of Esophageal Epithelial Neoplasia |
Date of disclosure of the study information | 2025/07/01 |
Last modified on | 2025/06/20 15:22:09 |
A Non-Inferiority Study of 0.8% Lugol's Iodine Staining versus 1.5% for the Detection of Esophageal Epithelial Neoplasia
A Non-Inferiority Study of 0.8% Lugol's Iodine Staining versus 1.5% for the Detection of Esophageal Epithelial Neoplasia
A Non-Inferiority Study of 0.8% Lugol's Iodine Staining versus 1.5% for the Detection of Esophageal Epithelial Neoplasia
A Non-Inferiority Study of 0.8% Lugol's Iodine Staining versus 1.5% for the Detection of Esophageal Epithelial Neoplasia
Japan |
Esophageal Squamous Cell Carcinoma
Hepato-biliary-pancreatic medicine |
Malignancy
NO
To evaluate the non-inferiority of 0.8% iodine staining compared to 1.5% iodine staining in the diagnostic performance for superficial esophageal squamous cell carcinoma.
Safety,Efficacy
Diagnostic accuracy of 0.8% iodine staining compared to 1.5% iodine staining for superficial esophageal squamous cell carcinoma
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Dose comparison
NO
NO
Institution is not considered as adjustment factor.
NO
2
Diagnosis
Medicine |
During esophagogastroduodenoscopy for esophageal cancer screening and surveillance, participants will undergo iodine staining with 1.5% iodine solution.
During esophagogastroduodenoscopy for esophageal cancer screening and surveillance, participants will undergo iodine staining with 0.8% iodine solution.
20 | years-old | <= |
89 | years-old | >= |
Male and Female
Individuals who are predicted in advance to require iodine staining during esophagogastroduodenoscopy for esophageal cancer screening or surveillance, based on being at high risk for esophageal cancer
Individuals who have received a full explanation of the study, fully understood its contents, and voluntarily agreed to participate by providing written informed consent
Individuals with an allergy to iodine
Individuals diagnosed with advanced esophageal cancer (those with a history of esophageal cancer may be included if the cancer has been cured)
Individuals with esophageal cancer of a histological type other than squamous cell carcinoma
Individuals who are unable to undergo biopsy
Individuals who have undergone iodine staining within the past month
Individuals who have undergone surgery involving the esophagus
Individuals who are deemed unsuitable for participation in the study by the principal investigator for any other reason
353
1st name | Shoko |
Middle name | |
Last name | Ono |
Hokkaido University Hospital
Division of Endoscopy
060-8648
Kita 14-jo Nishi 5-chome, Kita-ku, Sapporo, Hokkaido, Japan
011-716-1161
onosho@med.hokudai.ac.jp
1st name | Masaki |
Middle name | |
Last name | Inoue |
Hokkaido University Hospital
Division of Endoscopy
060-8648
Kita 14-jo Nishi 5-chome, Kita-ku, Sapporo, Hokkaido, Japan
011-716-1161
mokomokomomon@gmail.com
Hokkaido University
Self-funded
Self funding
Ethical Review Board for Life Science and Medical Research, Hokkaido University Hospital
Kita 14-jo Nishi 5-chome, Kita-ku, Sapporo, Hokkaido, Japan
011-706-7636
crjimu@huhp.hokudai.ac.jp
NO
2025 | Year | 07 | Month | 01 | Day |
Unpublished
Preinitiation
2025 | Year | 06 | Month | 20 | Day |
2025 | Year | 08 | Month | 01 | Day |
2029 | Year | 06 | Month | 30 | Day |
2025 | Year | 06 | Month | 20 | Day |
2025 | Year | 06 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066578